Sorrento Therapeutics, Inc. announced that Mr. George Uy, executive vice president and chief commercial officer, will be leaving the company at the end of July 2015 to join a start-up company as its chief executive officer.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0113 USD | -22.07% | +7.62% | -90.85% |
Apr. 10 | Sorrento Therapeutics, Inc. Emerged from Bankruptcy | CI |
Mar. 15 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
1st Jan change | Capi. | |
---|---|---|
-90.85% | 6.14M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.26% | 21.96B | |
-8.65% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- SRNE Stock
- News Sorrento Therapeutics, Inc.
- George Uy Leaves Sorrento Therapeutics, Inc. as Executive Vice President and Chief Commercial Officer